Chen Donglai, Mao Yiming, Wen Junmiao, Shu Jian, Ye Fei, She Yunlang, Ding Qifeng, Shi Li, Xue Tao, Fan Min, Chen Yongbing, Chen Chang
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai, People's Republic of China.
Department of Thoracic Surgery, Suzhou Kowloon Hospital Shanghai Jiaotong University School of Medicine, Suzhou, People's Republic of China.
JTO Clin Res Rep. 2020 Mar 23;1(3):100035. doi: 10.1016/j.jtocrr.2020.100035. eCollection 2020 Sep.
To determine the optimal number of examined lymph nodes (ELNs) and examined node stations (ENSs) in patients with radiologically pure-solid NSCLC and to investigate the impact of ELNs and ENSs on accurate staging and long-term survival.
Data from six institutions in the People's Republic of China on resected c-stage Ⅰ to Ⅱ NSCLCs presenting as pure-solid tumors were analyzed for the impact of ELNs and ENSs on nodal upstaging, stage migration, recurrence-free survival, and overall survival by using multivariate models. The correlations between different end points and ELNs or ENSs were fitted with a smoother (using Locally Weighted Scatterplot Smoothing tool), and the structural break points were determined by the Chow test.
Both ELNs and ENSs were identified as prognostic factors for overall survival (ENS: hazard ratio [HR], 0.697; 95% confidence interval [CI]: 0.590-0.824; < 0.001; ELN: HR, 0.945; 95% CI: 0.909-0.983; = 0.005) and recurrence-free survival (ENS: HR, 0.863; 95% CI: 0.791-0.941; = 0.001; ELN: HR, 0.960; 95% CI: 0.938-0.981; < 0.001). Intraoperative ELNs and ENSs were found to be associated with postoperative nodal upstaging. Cut point analysis revealed an optimal cutoff of 16 LNs and five node stations for patients with c-stage Ⅰ to Ⅱ pure-solid NSCLCs, which were examined in our multi-institutional cohort.
Both ELNs and ENSs are associated with more accurate node staging and better long-term survival. We recommend 16 LNs and five stations as the cut point for evaluating the quality of LN examination for c-stage Ⅰ to Ⅱ patients with radiologically pure-solid NSCLCs.
确定放射学表现为纯实性非小细胞肺癌(NSCLC)患者的最佳检查淋巴结数目(ELN)和检查淋巴结站数(ENS),并研究ELN和ENS对准确分期及长期生存的影响。
分析来自中华人民共和国六个机构的c期Ⅰ至Ⅱ期表现为纯实性肿瘤的NSCLC患者的切除数据,使用多变量模型研究ELN和ENS对淋巴结分期上调、分期迁移、无复发生存期和总生存期的影响。不同终点与ELN或ENS之间的相关性采用平滑器(使用局部加权散点图平滑工具)进行拟合,并通过Chow检验确定结构断点。
ELN和ENS均被确定为总生存期(ENS:风险比[HR],0.697;95%置信区间[CI]:0.590 - 0.824;P < 0.001;ELN:HR,0.945;95% CI:0.909 - 0.983;P = 0.005)和无复发生存期(ENS:HR,0.863;95% CI:0.791 - 0.941;P = 0.001;ELN:HR,0.960;95% CI:0.938 - 0.981;P < 0.001)的预后因素。术中ELN和ENS与术后淋巴结分期上调相关。切点分析显示,对于c期Ⅰ至Ⅱ期纯实性NSCLC患者,在我们的多机构队列中,最佳切点为16个淋巴结和五个淋巴结站。
ELN和ENS均与更准确的淋巴结分期及更好的长期生存相关。我们建议将16个淋巴结和五个站作为评估c期Ⅰ至Ⅱ期放射学表现为纯实性NSCLC患者淋巴结检查质量的切点。